Connect with us

Media & Technology

Internet of Things (IoT) Artificial Intelligence (AI) Technology; the Rise of Loop Insights Inc (OTCMKTS: RACMF) (CVE: MTRX)

Published

on

Loop Insights Inc (OTCMKTS: RACMF) (CVE: MTRX) is an exciting stock trading in both the USA and Canada that has seen an explosive rise over the past few months from pennies to multiple dollars per share. The Company has an ambitious vision to be the first publicly-traded, Artificial Intelligence, data play that delivers the ability to connect and to provide real-time data applications across the big three channels; In-Store, E-Commerce, and M-Commerce. Loop has not only accomplished this goal in 2020, it has begun to commercialize and build a strong pipeline of Tier-1 global brands. The Canadian Iot Market is projected to hit $21.8 billion by 2023

Loop just launched its second product into the Telus IoT Marketplace which will serve to significantly expand Loop’s sales distribution channels on a national scale. The Company’s first product accepted into the IoT Marketplace was its venue tracing service, which has received significant exposure to many of TELUS’s largest customers. The third-party validation that came with this acceptance has been instrumental in Loop’s venue tracing discussions with large corporate customers worldwide. Upon completion of the current Pilot rollout, the Company plans to rollout its Insights service to all TELUS corporate stores. On Monday Loop announced its BOD had approved its plan to up-list its shares to both the Toronto Stock Exchange (“TSX”), and the NASDAQ in the USA.

Loop Insights Inc (OTCMKTS: RACMF) (CVE: MTRX) is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network. Loop is currently preparing for the January 2021 launch of UKLIPZ, the first ever platform that enables consumers to create verified reviews using mobile video that can also be used, purchased or analyzed by brands and retailers to drive further engagement and sales. UKLIPZ was acquired by Loop on September 16th, 2019.

Earlier this year Loop formed a partnership with VenueNext, the global industry leader in point-of-sale (POS), mobile commerce and loyalty solutions for every major professional sports league and a number of colleges. VenueNext and Loop integrated the POS leader’s mobile ordering and payment functionality with Loop’s Real Time Dashboard, which provides clients with key insights on fans visiting arenas and stadiums at both the professional and collegiate levels, as well as, universities, theme parks, and more. Loop implemented its “Venue Bubble” at the Gulf Coast Showcase in Florida which is hosting 14 NCAA Division 1 men’s and women’s college basketball teams for the next month. On December 1 the Company reported the successful execution of its “Venue Bubble” solution in two separate live environments hosting NCAA Division 1 basketball teams.

On December 3 Loop announced the launch of a second product into the Telus IoT Marketplace which will serve to significantly expand Loop’s sales distribution channels on a national scale. On October 15th, Loop announced the significant milestone of having been accepted into the TELUS IoT Marketplace. The Company’s first product accepted into the IoT Marketplace was its venue tracing service, which has received significant exposure to many of TELUS’s largest customers and significant ongoing discussions with them. The third-party validation that came with this acceptance has been instrumental in Loop’s venue tracing discussions with large corporate customers worldwide.

To Find out the inside Scoop on Loop Insights Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

RACMF

Loop’s second product is its insights service and artificial intelligence insights portal used in pilot across 3 telus flagship retail locations. On September 17th, Loop announced an agreement with TELUS to conduct a 90-day proof of concept pilot across TELUS’s three flagship corporate retail locations in British Columbia. TELUS deployed Loop’s Insights service, which consists of its IoT Fobi device, Loop Cloud API, and AI Insights Portal to test and leverage its automated marketing capabilities. Connected between the printer and point of sale, Loop’s Fobi device’s real-time capabilities are driven by Artificial Intelligence to enhance the shopping experience. Providing data-driven product suggestions and unique discount codes for future use, Loop enables TELUS’s customers to increase revenues through increased spend per customer.

The first goal of the Pilot, assuming a successful completion, was for Loop to achieve exponential scale through a channel reseller distribution partnership for our Insights service with TELUS, which has now been achieved. This acceptance into the TELUS IoT Marketplace provides Loop with national sales and marketing exposure to TELUS business customers. The second goal of the Pilot is a rollout of the Company’s Insights service to all TELUS corporate stores. On November 4th, Loop announced the successful completion of a 20 location pilot with a leading US-based retailer, resulting in a rollout to 550 locations. The Canadian Iot Market is projected to hit $21.8 billion by 2023. The importance of this TELUS IoT Marketplace distribution channel to Loop is critical and timely, given the growth of IoT in Canada over just the next couple of years. IoT Investment in Canada alone is growing exponentially, which will require companies and organizations to make fast decisions with respect to solutions. The Company’s TELUS recognition and acceptance will make it much easier for those decision-makers to choose Loop.

On Monday Loop announced its BOD had approved its plan to up-list its shares to a major North American Stock Exchanges. The Up-list Plan outlines Loop’s proposed plan to apply to have its common shares up-listed to the Toronto Stock Exchange (“TSX”), as a technology company, from the TSX Venture Exchange (“TSXV”).  Secondly, if the Company is successful in up-listing to the TSX, Loop intends to, as soon as practical, begin the process of filing a Form F-1 Registration Statement which will enable Loop to apply to be listed on the NASDAQ.

Loop Insights CEO Rob Anson stated: “As a result of our immutable relevancy, high demand for Loop’s products, pipeline growth, and ability to easily scale into a global marketplace that is in full press digital transformation, we expect a continued accelerated pace that now warrants an uplist and dual list strategy that will attract institutional investors commensurate with our anticipated profile in 2021 and far beyond.”

For More on Loop Insights Subscribe Right Now!

Currently making a powerful move up the charts Loops Insights is an exciting stock trading in both the USA and Canada that has seen an explosive rise over the past few months from pennies to multiple dollars per share. The Company has an ambitious vision to be the first publicly-traded, Artificial Intelligence, data play that delivers the ability to connect and to provide real-time data applications across the big three channels; In-Store, E-Commerce, and M-Commerce. Loop has not only accomplished this goal in 2020, it has begun to commercialize and build a strong pipeline of Tier-1 global brands. The Canadian Iot Market is projected to hit $21.8 billion by 2023. Loop just launched its second product into the Telus IoT Marketplace which will serve to significantly expand Loop’s sales distribution channels on a national scale. The Company’s first product accepted into the IoT Marketplace was its venue tracing service, which has received significant exposure to many of TELUS’s largest customers. The third-party validation that came with this acceptance has been instrumental in Loop’s venue tracing discussions with large corporate customers worldwide. Upon completion of the current Pilot rollout, the Company plans to rollout its Insights service to all TELUS corporate stores. On Monday Loop announced its BOD had approved its plan to up-list its shares to both the Toronto Stock Exchange (“TSX”), and the NASDAQ in the USA. We will be updating on Loop Insights when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Loop Insights.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in Loop Insights either long or short and we have not been compensated for this article

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

LAVA Therapeutics (NASDAQ: LVTX) Gammabody™ Platform Gains Momentum

Published

on

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc. chose a lead candidate.

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc., a part of the Janssen Pharmaceutical Companies of Johnson & Johnson, chose a lead candidate aimed at an undisclosed tumor-associated antigen for further development towards clinical settings.

GAMMABODY™ PLATFORM

LAVA primarily focuses on revolutionizing cancer therapy by developing its Gammabody™ platform. This platform enables them to create bispecific gamma delta T cell engagers that can activate a specific subset of gamma-delta T cells called Vγ9Vδ2 (Vgamma9 Vdelta2) T cells. By utilizing this approach, they aim to enhance the natural recognition of tumors, guide Vγ9Vδ2 T cells to target the tumor cells directly and trigger a cascade of immune responses.

To Discover the Inside Scoop on LVTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

What sets their Gammabody™ drug candidates apart is their exceptional performance and safety profiles observed in preclinical studies. Compared to other bispecific T cell engager approaches, their candidates have demonstrated superior efficacy and preferred targeting tumor cells. This targeted approach has the potential to minimize toxicity in healthy tissues.

In May 2020, LAVA entered into a research collaboration and license agreement with Janssen, a subsidiary of the Janssen Pharmaceutical Companies of Johnson & Johnson. This collaboration aimed to discover and develop novel bispecific antibody-based gamma delta T cell engagers for cancer treatment. The agreement was facilitated by Johnson & Johnson Innovation, emphasizing their commitment to fostering innovation in the field.

As part of the collaboration, LAVA had the opportunity to receive potential milestone payments and royalties based on the successful development, regulatory approvals, and commercialization of the candidates. This incentivized LAVA to actively pursue the discovery and advancement of promising lead candidates. 

The collaboration represents a remarkable milestone many early-stage biotech companies aspire to achieve. Partnering with a program brings numerous benefits, including reduced risk of dilution through milestone payments as the trials advance and streamlined commercialization once the product receives approval.

Under the terms of the agreement, Janssen will assume responsibility for the selected candidate’s future clinical development, manufacturing, and commercialization. This includes bearing the costs and expenses associated with these activities.

Stephen Hurly, LAVA Therapeutics’s president and chief executive officer, expressed satisfaction with Janssen’s selection of a lead candidate for clinical studies. He emphasized LAVA’s pioneering role in developing gamma-delta bispecific antibodies through their proprietary Gammabody platform. This platform and LAVA’s extensive expertise in bispecific antibody development position them at the forefront of advancing novel therapies for cancer patients.

In summary, LAVA Therapeutics’ collaboration with Janssen has reached a significant milestone in selecting a lead candidate for further development toward clinical studies. This progress underscores LAVA’s dedication to leveraging its Gammabody platform and expertise in bispecific antibody development to revolutionize cancer treatment.

We will update you on LVTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Continue Reading

Featured

Onfolio Holdings (NASDAQ: ONFO) Unleashing the Power of AI

Published

on

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com.

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com. The implementation of this innovative AI tool, powered by chatGPT-style Large Language Models (LLMs), has resulted in a surge of 105% in the company’s stock price and sparked tons of investor interest. The company has a 3.28M float and, at the time of writing, has traded 20x that amount, with a colossal 60M shares exchanging hands.

Revolutionizing User Experience and Driving Stock Surge

With the integration of AI search on MightyDeals.com, customers can now use natural language to describe the products they seek, simplifying the buying process. The AI tool utilizes contextual understanding and description analysis of hundreds of active deals to generate instant search results based on users’ queries. By enhancing the user experience, Onfolio Holdings anticipates increased user return rates, higher site interaction rates, and elevated revenues for MightyDeals.com. This groundbreaking development has attracted positive attention, significantly increasing Onfolio Holdings’ stock price.

To Discover the Inside Scoop on ONFO, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Evaluating Financial Performance

While the stock surge indicates investor enthusiasm, assessing Onfolio Holdings’ financial performance is crucial for comprehensive investment analysis. The positive earnings growth of +44.44% and revenue growth of +22.74% contribute to the company’s optimistic outlook. However, investors should be cautious of the negative net profit margin of -190.75% and the lack of available price/book ratio data. Monitoring the company’s financial performance leading up to the next reporting date on August 30, 2023, is advised to understand its profitability and overall stability better.

Investment Outlook and Future Prospects

Considering the stock surge and optimistic price forecasts, Onfolio Holdings has promising prospects. Analysts offer a median target price of $3.00 for the company’s stock, signaling an expectation of significant growth within the next 12 months. However, it is essential to note that Onfolio Holdings operates at a loss. Investors should thoroughly evaluate the company’s long-term growth potential and weigh the potential returns against the inherent risks before making investment decisions.

About MightyDeals.com

Mighty Deals is a free daily deals website aimed at creative professionals focusing on products and services for web designers and developers. The site offers fantastic deals on quality fonts, templates, apps, add-ons, plug-ins, ebooks, icons, and more. The site provides discounts on packages which usually range between 50%-97% off but are only available for a limited time. MightyDeals.com boasts an exceptional return rate from its users and is one of Onfolio Holdings’ highest revenue-generating subsidiaries.

About Onfolio Holdings Inc.

Onfolio acquires and manages a diversified portfolio of online businesses across a broad range of verticals, each with a niche content focus and brand identity. Onfolio acquires firms that meet its investment criteria, being that such businesses operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by our existing team or have strong management teams largely in place. The Company excels at finding acquisition opportunities where the seller has not fully optimized their business. Onfolio’s experience and skillset allow it to add increased value to these existing businesses.

Conclusion

Onfolio Holdings’ introduction of the generative AI search function for MightyDeals.com has increased the company’s stock price, reflecting the market’s positive response to this innovative technology. The enhanced user experience and the potential for increased revenues have positioned Onfolio Holdings as a leader in the tech industry. However, investors must carefully consider the company’s financial performance and evaluate its long-term growth potential before making investment decisions. Monitoring the company’s performance to the next reporting date will provide valuable insights into its financial health and stability.

We will update you on ONFO when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by James from Pixabay

Continue Reading

Featured

Enveric Biosciences (NASDAQ: ENVB) Pioneering the Future of Anxiety Disorder Treatment

Published

on

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news.

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news. The United States Patent and Trademark Office has granted them a notice of allowance for their patent application concerning a groundbreaking chemical compound called EB-373. This compound is being developed to address the treatment of anxiety disorders.

The forthcoming patent, titled “C4-Carbonothioate-Substituted Tryptamine Derivatives and Methods of Using,” encompasses claims for the composition of matter of a family of revolutionary prodrug derivatives of psilocin. Enveric’s lead product candidate, EB-373, stands out among these derivatives. A Notice of Allowance signifies that the USPTO has determined that a patent should be granted based on the submitted application.

To Discover the Inside Scoop on ENVB, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Enveric’s commitment to innovation extends beyond EB-373. They have also submitted additional patent applications to the USPTO, exploring psilocin prodrugs with unique crystalline molecular structures. Moreover, they have taken proactive steps to pursue global coverage of the EVM201 and EVM301 Series through companion Patent Cooperation Treaty and non-US national patent applications. Encouragingly, positive International Search Reports and written opinions have been received under the Patent Cooperation Treaty for most of these applications.

Joseph Tucker, Ph.D., Enveric’s director and CEO, underlined the significance of the USPTO’s favorable decision concerning their lead candidate, EB-373. He highlighted the innovative designs of their psilocin prodrugs within the EVM201 series, differentiating them from conventional counterparts like psilocybin. These novel designs hold the potential to deliver more rapid therapeutic effects, precise control, and reduced gastrointestinal side effects. Tucker emphasized that securing a robust intellectual property portfolio for their new chemical entity prodrugs is pivotal to Enveric’s value proposition and integral to their business strategy of developing cutting-edge small-molecule therapeutics to address mental health disorders.

We will update you on ENVB when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gino Crescoli from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.